David D. Clark's most recent trade in Amicus Therapeutics Inc was a trade of 52,338 Common Stock done . Disclosure was reported to the exchange on Feb. 11, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 52,338 | 368,854 (0%) | 0% | 0 | Common Stock | |
Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.57 per share. | 11 Feb 2025 | 20,593 | 348,261 (0%) | 0% | 9.6 | 197,075 | Common Stock |
Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 125,430 | 125,430 | - | - | Stock Options (right to buy) | |
Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 69,228 | 331,195 (0%) | 0% | 0 | Common Stock | |
Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.41 per share. | 02 Jan 2025 | 11,987 | 319,208 (0%) | 0% | 9.4 | 112,798 | Common Stock |
Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.31 per share. | 02 Jan 2025 | 5,381 | 261,967 (0%) | 0% | 9.3 | 50,097 | Common Stock |
Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.41 per share. | 02 Jan 2025 | 2,692 | 316,516 (0%) | 0% | 9.4 | 25,332 | Common Stock |
Kennametal Inc. | Clark David Bersaglini | Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Sep 2024 | 11,596 | 11,596 | - | - | Restricted Stock Units | |
Kennametal Inc. | Clark David Bersaglini | Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Sep 2024 | 10,050 | 10,050 | - | - | Restricted Stock Units | |
O-I Glass Inc | David V. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 10,933 | 28,418 (0%) | 0% | 0 | Common Stock (Direct) | |
Jetblue Airways Corp | David Christopher Clark | Head of Revenue and Planning | Grant, award, or other acquisition of securities at price $ 5.02 per share. | 30 Apr 2024 | 1,590 | 29,466 (0%) | 0% | 5.0 | 7,974 | Common Stock |
Jetblue Airways Corp | David Christopher Clark | Head of Revenue and Planning | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Apr 2024 | 10,608 | 31,701 (0%) | 0% | - | Common Stock | |
Jetblue Airways Corp | David Christopher Clark | Head of Revenue and Planning | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Apr 2024 | 10,608 | 21,216 | - | - | Restricted Stock Units | |
Jetblue Airways Corp | David Christopher Clark | Head of Revenue and Planning | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.83 per share. | 11 Apr 2024 | 3,825 | 27,876 (0%) | 0% | 6.8 | 26,125 | Common Stock |
Jetblue Airways Corp | Clark Christopher David | Head of Revenue and Planning | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 32,786 | 32,786 | - | - | Restricted Stock Units | |
Jetblue Airways Corp | David Christopher Clark | Head of Revenue and Planning | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2024 | 3,048 | 22,192 (0%) | 0% | - | Common Stock | |
Jetblue Airways Corp | Christopher Clark David | Head of Revenue and Planning | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2024 | 3,048 | 0 | - | - | Restricted Stock Units | |
Jetblue Airways Corp | Clark David Christopher | Head of Revenue and Planning | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2024 | 2,614 | 20,087 (0%) | 0% | - | Common Stock | |
Jetblue Airways Corp | Christopher David Clark | Head of Revenue and Planning | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2024 | 2,614 | 2,615 | - | - | Restricted Stock Units | |
Jetblue Airways Corp | Clark Christopher David | Head of Revenue and Planning | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.54 per share. | 22 Feb 2024 | 1,099 | 21,093 (0%) | 0% | 6.5 | 7,187 | Common Stock |
Jetblue Airways Corp | David Clark Christopher | Head of Revenue and Planning | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.54 per share. | 22 Feb 2024 | 943 | 19,144 (0%) | 0% | 6.5 | 6,167 | Common Stock |
Trevi Therapeutics Inc | Clark David J. | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 175,000 | 175,000 | - | - | Stock Option (right to buy) | |
Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 15 Feb 2024 | 4,427 | 253,664 (0%) | 0% | 14 | 61,978 | Common Stock |
Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2024 | 13,684 | 280,389 (0%) | 0% | 0 | Common Stock | |
Amicus Therapeutics Inc | Michael David Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.65 per share. | 09 Jan 2024 | 8,614 | 258,091 (0%) | 0% | 13.6 | 117,581 | Common Stock |
Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.65 per share. | 09 Jan 2024 | 8,614 | 271,775 (0%) | 0% | 13.6 | 117,581 | Common Stock |
Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 08 Jan 2024 | 8,726 | 268,089 (0%) | 0% | 14 | 122,164 | Common Stock |
Amicus Therapeutics Inc | Michael David Clark | Chief People Officer | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 08 Jan 2024 | 1,384 | 266,705 (0%) | 0% | 14 | 19,376 | Common Stock |
Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.44 per share. | 04 Jan 2024 | 2,692 | 276,815 (0%) | 0% | 13.4 | 36,180 | Common Stock |
Amicus Therapeutics Inc | Clark David Michael | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 83,221 | 83,221 | - | - | Stock Options (right to buy) | |
Amicus Therapeutics Inc | Clark David Michael | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 48,209 | 297,488 (0%) | 0% | 0 | Common Stock | |
Amicus Therapeutics Inc | Clark Michael David | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.53 per share. | 02 Jan 2024 | 11,650 | 279,507 (0%) | 0% | 13.5 | 157,625 | Common Stock |
Amicus Therapeutics Inc | Clark Michael David | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.24 per share. | 02 Jan 2024 | 6,331 | 291,157 (0%) | 0% | 14.2 | 90,153 | Common Stock |
Amicus Therapeutics Inc | Clark Michael David | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2023 | 8,212 | 249,279 (0%) | 0% | 0 | Common Stock | |
O-I Glass Inc | David V. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 6,683 | 17,485 (0%) | 0% | 0 | Common Stock (Direct) | |
Jetblue Airways Corp | David Christopher Clark | Head of Revenue and Planning | Grant, award, or other acquisition of securities at price $ 5.91 per share. | 28 Apr 2023 | 1,114 | 16,397 (0%) | 0% | 5.9 | 6,582 | Common Stock |
Jetblue Airways Corp | David Christopher Clark | Head of Revenue and Planning | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Apr 2023 | 31,824 | 31,824 | - | - | Restricted Stock Units | |
Jetblue Airways Corp | David Christopher Clark | Head of Revenue and Planning | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Apr 2023 | 28,288 | 28,288 | - | - | Restricted Stock Units | |
Jetblue Airways Corp | David Christopher Clark | Head of Revenue and Planning | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2023 | 3,653 | 0 | - | - | Restricted Stock Units | |
Jetblue Airways Corp | David Christopher Clark | Head of Revenue and Planning | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2023 | 3,653 | 16,600 (0%) | 0% | - | Common Stock | |
Jetblue Airways Corp | David Christopher Clark | Head of Revenue and Planning | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2023 | 3,048 | 3,048 | - | - | Restricted Stock Units | |
Jetblue Airways Corp | David Christopher Clark | Head of Revenue and Planning | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2023 | 3,048 | 14,046 (0%) | 0% | - | Common Stock | |
Jetblue Airways Corp | David Christopher Clark | Head of Revenue and Planning | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2023 | 2,614 | 5,229 | - | - | Restricted Stock Units | |
Jetblue Airways Corp | David Christopher Clark | Head of Revenue and Planning | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2023 | 2,614 | 11,941 (0%) | 0% | - | Common Stock | |
Jetblue Airways Corp | David Christopher Clark | Head of Revenue and Planning | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.15 per share. | 23 Feb 2023 | 1,317 | 15,283 (0%) | 0% | 8.2 | 10,734 | Common Stock |
Jetblue Airways Corp | David Christopher Clark | Head of Revenue and Planning | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.27 per share. | 23 Feb 2023 | 1,099 | 12,947 (0%) | 0% | 8.3 | 9,089 | Common Stock |
Jetblue Airways Corp | David Christopher Clark | Head of Revenue and Planning | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.20 per share. | 23 Feb 2023 | 943 | 10,998 (0%) | 0% | 8.2 | 7,733 | Common Stock |
Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Sale of securities on an exchange or to another person at price $ 13.50 per share. | 18 Jan 2023 | 7,382 | 241,067 (0%) | 0% | 13.5 | 99,657 | Common Stock |
Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2023 | 47,621 | 267,187 (0%) | 0% | 0 | Common Stock | |
Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.02 per share. | 11 Jan 2023 | 18,738 | 248,449 (0%) | 0% | 12.0 | 225,231 | Common Stock |
Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Sale of securities on an exchange or to another person at price $ 11.87 per share. | 04 Jan 2023 | 21,507 | 219,566 (0%) | 0% | 11.9 | 255,346 | Common Stock |
Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.03 per share. | 04 Jan 2023 | 2,692 | 241,073 (0%) | 0% | 12.0 | 32,385 | Common Stock |
Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2023 | 105,388 | 105,388 | - | - | Stock Options (right to buy) | |
Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2023 | 59,372 | 249,575 (0%) | 0% | 0 | Common Stock | |
Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.21 per share. | 02 Jan 2023 | 11,336 | 198,696 (0%) | 0% | 12.2 | 138,413 | Common Stock |
Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Sale of securities on an exchange or to another person at price $ 12.03 per share. | 02 Jan 2023 | 8,493 | 190,203 (0%) | 0% | 12.0 | 102,176 | Common Stock |
Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.93 per share. | 02 Jan 2023 | 5,810 | 243,765 (0%) | 0% | 11.9 | 69,313 | Common Stock |
Jetblue Airways Corp | David Christopher Clark | Head of Revenue and Planning | Grant, award, or other acquisition of securities at price $ 6.60 per share. | 31 Oct 2022 | 469 | 9,327 (0%) | 0% | 6.6 | 3,094 | Common Stock |
Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.40 per share. | 09 Oct 2022 | 5,510 | 210,032 (0%) | 0% | 10.4 | 57,304 | Common Stock |
Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Sale of securities on an exchange or to another person at price $ 12.50 per share. | 05 Aug 2022 | 11,322 | 215,542 (0%) | 0% | 12.5 | 141,525 | Common Stock |
Amazon.com Inc. | David H. Clark | CEO Worldwide Consumer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2022 | 4,000 | 12,000 | - | - | Restricted Stock Unit Award | |
Amazon.com Inc. | David H. Clark | CEO Worldwide Consumer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2022 | 4,000 | 8,965 (0%) | 0% | 0 | Common Stock, par value $.01 per share | |
Amazon.com Inc. | David H. Clark | CEO Worldwide Consumer | Sale of securities on an exchange or to another person at price $ 2169.22 per share. | 21 May 2022 | 2,270 | 6,695 (0%) | 0% | 2169.2 | 4,924,129 | Common Stock, par value $.01 per share |
Amazon.com Inc. | David H. Clark | CEO Worldwide Consumer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2022 | 1,040 | 4,965 (0%) | 0% | 0 | Common Stock, par value $.01 per share | |
Amazon.com Inc. | David H. Clark | CEO Worldwide Consumer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2022 | 1,040 | 6,334 | - | - | Restricted Stock Unit Award | |
Amazon.com Inc. | David H. Clark | CEO Worldwide Consumer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2022 | 364 | 3,925 (0%) | 0% | 0 | Common Stock, par value $.01 per share | |
Amazon.com Inc. | David H. Clark | CEO Worldwide Consumer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2022 | 364 | 9,536 | - | - | Restricted Stock Unit Award | |
O-I Glass Inc | David V. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2022 | 10,802 | 10,802 (0%) | 0% | 0 | Common Stock (Direct) | |
Jetblue Airways Corp | David Christopher Clark | Head of Revenue and Planning | Grant, award, or other acquisition of securities at price $ 9.70 per share. | 29 Apr 2022 | 556 | 8,858 (0%) | 0% | 9.7 | 5,393 | Common Stock |
Amazon.com Inc. | David H. Clark | CEO Worldwide Consumer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2022 | 4,989 | 4,989 | - | - | Restricted Stock Unit Award | |
Jetblue Airways Corp | David Christopher Clark | Head of Revenue and Planning | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2022 | 3,865 | 0 | - | - | Restricted Stock Units | |
Jetblue Airways Corp | David Christopher Clark | Head of Revenue and Planning | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2022 | 3,865 | 7,341 (0%) | 0% | - | Common Stock | |
Jetblue Airways Corp | David Christopher Clark | Head of Revenue and Planning | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2022 | 3,653 | 3,653 | - | - | Restricted Stock Units | |
Jetblue Airways Corp | David Christopher Clark | Head of Revenue and Planning | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2022 | 3,653 | 9,619 (0%) | 0% | - | Common Stock | |
Jetblue Airways Corp | David Christopher Clark | Head of Revenue and Planning | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2022 | 3,047 | 6,096 | - | - | Restricted Stock Units | |
Jetblue Airways Corp | David Christopher Clark | Head of Revenue and Planning | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2022 | 3,047 | 4,575 (0%) | 0% | - | Common Stock | |
Jetblue Airways Corp | David Christopher Clark | Head of Revenue and Planning | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.52 per share. | 25 Feb 2022 | 1,375 | 5,966 (0%) | 0% | 15.5 | 21,340 | Common Stock |
Jetblue Airways Corp | David Christopher Clark | Head of Revenue and Planning | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.52 per share. | 25 Feb 2022 | 1,317 | 8,302 (0%) | 0% | 15.5 | 20,440 | Common Stock |
Jetblue Airways Corp | David Christopher Clark | Head of Revenue and Planning | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.14 per share. | 25 Feb 2022 | 1,099 | 3,476 (0%) | 0% | 15.1 | 16,639 | Common Stock |
Jetblue Airways Corp | David Christopher Clark | Head of Revenue and Planning | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 7,843 | 7,843 | - | - | Restricted Stock Units | |
Amazon.com Inc. | David H. Clark | CEO Worldwide Consumer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2022 | 190 | 9,900 | - | - | Restricted Stock Unit Award | |
Amazon.com Inc. | David H. Clark | CEO Worldwide Consumer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2022 | 190 | 3,698 (0%) | 0% | 0 | Common Stock, par value $.01 per share | |
Amazon.com Inc. | David H. Clark | CEO Worldwide Consumer | Sale of securities on an exchange or to another person at price $ 3009.57 per share. | 21 Feb 2022 | 137 | 3,561 (0%) | 0% | 3009.6 | 412,311 | Common Stock, par value $.01 per share |
Amazon.com Inc. | David H. Clark | CEO Worldwide Consumer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 1,426 | 4,535 (0%) | 0% | 0 | Common Stock, par value $.01 per share | |
Amazon.com Inc. | David H. Clark | CEO Worldwide Consumer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2022 | 1,426 | 0 | - | - | Restricted Stock Unit Award | |
Amazon.com Inc. | David H. Clark | CEO Worldwide Consumer | Sale of securities on an exchange or to another person at price $ 3150.92 per share. | 15 Feb 2022 | 1,027 | 3,508 (0%) | 0% | 3150.9 | 3,235,995 | Common Stock, par value $.01 per share |
Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 108,266 | 108,266 | - | - | Stock Options (right to buy) | |
Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 59,071 | 207,313 (0%) | 0% | - | Common Stock | |
Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 32,235 | 239,548 (0%) | 0% | - | Common Stock | |
Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.53 per share. | 14 Jan 2022 | 12,684 | 226,864 (0%) | 0% | 10.5 | 133,563 | Common Stock |
Amazon.com Inc. | David H. Clark | CEO Worldwide Consumer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2021 | 190 | 10,090 | - | - | Restricted Stock Unit Award | |
Amazon.com Inc. | David H. Clark | CEO Worldwide Consumer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2021 | 190 | 3,214 (0%) | 0% | 0 | Common Stock, par value $.01 per share | |
Amazon.com Inc. | David H. Clark | CEO Worldwide Consumer | Sale of securities on an exchange or to another person at price $ 3676.00 per share. | 21 Nov 2021 | 105 | 3,109 (0%) | 0% | 3676 | 385,980 | Common Stock, par value $.01 per share |
Amazon.com Inc. | David H. Clark | CEO Worldwide Consumer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2021 | 1,426 | 1,426 | - | - | Restricted Stock Unit Award | |
Amazon.com Inc. | David H. Clark | CEO Worldwide Consumer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2021 | 1,426 | 3,809 (0%) | 0% | 0 | Common Stock, par value $.01 per share | |
Amazon.com Inc. | David H. Clark | CEO Worldwide Consumer | Sale of securities on an exchange or to another person at price $ 3537.00 per share. | 15 Nov 2021 | 785 | 3,024 (0%) | 0% | 3537 | 2,776,545 | Common Stock, par value $.01 per share |
Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.51 per share. | 09 Oct 2021 | 5,510 | 168,879 (0%) | 0% | 11.5 | 63,420 | Common Stock |
Amazon.com Inc. | David H. Clark | CEO Worldwide Consumer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Aug 2021 | 190 | 10,280 | - | - | Restricted Stock Unit Award | |
Amazon.com Inc. | David H. Clark | CEO Worldwide Consumer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Aug 2021 | 190 | 2,488 (0%) | 0% | 0 | Common Stock, par value $.01 per share | |
Amazon.com Inc. | David H. Clark | CEO Worldwide Consumer | Sale of securities on an exchange or to another person at price $ 3211.90 per share. | 21 Aug 2021 | 105 | 2,383 (0%) | 0% | 3211.9 | 337,250 | Common Stock, par value $.01 per share |
Amazon.com Inc. | David H. Clark | CEO Worldwide Consumer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2021 | 1,425 | 2,852 | - | - | Restricted Stock Unit Award |